< Home < Back

Venus Remedies - Quaterly Results

Date: 27-10-2026
The September 2026 quarter revenue stood at Rs. 2187.60 millions, up 13.55% as compared to Rs. 1926.50 millions during the corresponding quarter last year.Net profit for the quarter ended September 2026 increased significantly by 50.52% to Rs. 289.60 millions from Rs. 192.40 millions.The company reported a good operating profit of 460.40 millions compared to 315.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 2187.60 1926.50 13.55 3975.60 3297.80 20.55 7687.30 6444.70 19.28
Other Income 4.00 16.80 -76.19 29.50 44.00 -32.95 114.60 157.70 -27.33
PBIDT 460.40 315.20 46.07 851.50 521.70 63.22 1553.70 907.70 71.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 460.40 315.20 46.07 851.50 521.70 63.22 1553.70 1006.80 54.32
Depreciation 92.70 59.20 56.59 157.80 118.70 32.94 246.90 216.20 14.20
PBT 367.70 256.00 43.63 693.70 403.00 72.13 1306.80 790.60 65.29
TAX 78.10 63.60 22.80 148.80 93.70 58.80 313.70 265.10 18.33
Deferred Tax -14.40 -0.90 1500.00 -25.70 -7.80 229.49 -15.20 46.50 -132.69
PAT 289.60 192.40 50.52 544.90 309.30 76.17 993.10 525.50 88.98
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 21.05 16.36 28.63 21.42 15.82 35.39 20.21 14.08 43.50